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The main sector of agriculture in Kazakhstan, including the East Kazakhstan region is cattle breeding 
and, in particular, cattle breeding, which is determined by climatic and geographical conditions. However, 
successful reproduction and increase in livestock productivity is largely hampered by infertility and masti-
tis, and as a result they cause significant economic damage and reduce the reproduction rate and profitabil-
ity of dairy cattle. Recently, the number of subclinical mastitis in cows has increased, which subsequently 
lead to profound morphological and functional changes in the mammary gland, a decrease in milk produc-
tivity and quality. Mastitis can be caused by various reasons, primarily poor or inadequate feeding, poor 
care, improper maintenance and use of animals, negligent attitudes towards organizing and conducting 
artificial insemination, due to various diseases of the genital organs, which appear most often during child-
birth and the postpartum period. The quality control of the milk of cows was investigated by California test 
and DEDM (Device for Express Diagnostic of Mastitis). The express methods that we used allowed us to 
identify the subclinical and clinical forms of mastitis and timely treat it. Laboratory studies on the presence 
of somatic cells in milk were also conducted. After the detection of breast diseases, complex symptomatic 
treatment was performed. For the treatment of various forms of mastitis, drugs were used: mastiet forte - 
intracisternally for five days at a dose of 10 ml 2 times a day for five days in a row. Mastiet Forte has a high 
therapeutic efficacy in subclinical and clinical forms of cow mastitis. And the drug ketoprof  has also been 
used. Ketoprof  as an anti-inflammatory agent was used intramuscularly – 3 ml per 100 kg of animal weight 
1 time per day for 3 days in a row. Klineksin 5%, as an antibacterial agent, was used intramuscularly at a 
dose of 1 ml per 50 kg of body weight 1 time per day for 3 days in a row. Antimicrobial agents and biologi-
cally active substances needed to be combined for successful therapy. Such biologically active substances 
include vitamin of Helsivit. They were used subcutaneously – 6 ml once. 
 
Key words: mastitis, milk, udder, diagnostics, California test, Mastiet forte, ketoprof, klineksin 5%,  
vitamin of helsivit, Laktan1-4M. 
 
Introduction 
 
One of the most valuable food is milk. The main way 
to increase its production is the creation of healthy, highly 
productive herds. The concentration of livestock on large 
farms and complexes, the mechanization of basic produc-
tion processes, including milking, revealed to the special-
ists a number of serious problems for the prevention of 
serious diseases. A special place in them are breast dis-
eases, which significantly affect the productivity of ani-
mals, reduce the quality of milk. 
Getting a high-quality and safe cow milk is an actual 
task for dairy farms (Vasiliev, 2012; Verkholomov, 2012; 
Larionov et al., 2012; Shepeleva, 2012; Rodionov et al., 
2012; Rodionov, et al., 2013; Chikina, 2013). 
The genetic potential of the livestock of cattle herds, 
the quantity, balance and safety of the feed, housing con-
ditions, milking technology and cow care have a complex 
effect on milk production and milk quality (Schukken et 
al., 1993; Zhelavskyi, 2018). 
Mastitis of cows causes significant damage to farms 
due to reduced milk quality and productivity of cows, 
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treatment costs, premature culling of cows (Hulps et al., 
2010; Bagmanov, 2011; Kolchina et al., 2012). 
According to foreign studies, subclinical mastitis is 
recorded in 90% of cases, whereas clinically significant 
inflammation occurs only in 3–10% (Bekken & Thorburn, 
1985). 
In the milk of cows with mastitis, there are significant 
physical and chemical changes, as a result of which it 
becomes a low-value food product and loses its techno-
logical properties during industrial processing. In addi-
tion, mammary gland inflammation leads to hypogalactia 
and, in some cases, to complete atrophy of the affected 
quarter of the udder. With subclinical mastitis, one udder 
lobe from each sick cow loses on average up to 10–15% 
of milk per lactation. Therefore, it is necessary to intro-
duce into the milk production technology a complex of 
effective preventive measures to fight breast diseases in 
cows, in particular, mastitis (Krukowski, 2000; Malinow-
ski, 2004). 
For successful treatment of mastitis of cows, it is nec-
essary to combine antimicrobial agents and biologically 
active substances. Such biologically active substances 
include vitamins, enzymes, hormones and micro ele-
ments, yeast, probiotics.These substances contribute to 
the normalization of metabolism in animals, activate the 
system of natural resistance, and thereby contribute to the 
effectiveness of anti-mastitis therapy (Parikov, 1990). 
Until recently, the main treatment for mastitis was an-
tibacterial therapy. The effectiveness of the use of antibi-
otics depends on many factors, but the determining factor 
is the specific features of interaction of the antibiotic 
directly with the pathogen. The processes of interaction 
between the antibacterial agent and the antibiotic are 
determined by the pharmacokinetic characteristics of the 
drug, the sensitivity of the microorganism to it, and the 
ability of the bacteria to “defend” (develop resistance). 
The development of antimicrobial resistance in many 
bacterial pathogens makes the treatment with traditional 
anti-mastitis drugs ineffective, which makes the veterinar-
ian to “pick up” a more effective remedy by successively 
changing the group of antibiotics or a combination of 
different drugs.However, such approach often cannot be 
acceptable, since in acute clinical mastitis a quick and 
pronounced effect is required (Oleinik, 2008). 
Also, one of the causes of this pathology may be the 
uncontrolled use of antibiotics, which in turn causes the 
formation of antibiotic-resistant microorganisms, leading 
to the occurrence of the disease (Atheer et al., 2018). 
The main method of preventing diseases of the udder 
is a scientifically-based, cost-effective management of 
livestock while observing zoohygienic standards of hous-
ing, feeding and milking, which provide a high level of 
natural resistance of the body and animal productivity. 
The aim of this work was to study the therapeutic effi-
cacy of applying the method of treating cows with sub-
clinical and clinical mastitis. 
 
Materials and methods 
 
The cows of the farms of “Balke”, “Kalikhanuly” and 
“Madi-R” served as the material, where we conducted a 
study on subclinical and clinical forms of mastitis. 
120 dairy cows of the black-and- motley breed at the 
age of 5–6 years with a body weight of 450–500 kg were 
used for research. 
The diagnosis was established on the basis of the col-
lection of anamnesis of clinical and laboratory research 
results. 
The quality control of the milk of cows was investi-
gated by the California test and DEDM (Device for Ex-
press Diagnostic of Mastitis). 
The express methods that we used allowed us to iden-
tify the subclinical and clinical forms of mastitis and 
timely treat it. Laboratory studies on the presence of so-
matic cells in milk were also conducted. 
After the detection of mammary gland diseases, com-
plex symptomatic treatment was performed. 
 
Results and discussion 
 
During the study of 120 cows, 53.3% of cases of sub-
clinical form of mastitis were detected, and the clinical 
forms of mastitis were 12.4%. 
In addition, laboratory tests were conducted for the 
presence of somatic cells in milk by the Laktan1-4 M 
apparatus and the California test. So, at the beginning of 
the experience, their number was determined within  
590 thousand – 620 thousand, which is typical for sub-
clinical mastitis. The data obtained as a result of the re-
search are presented in table 1. 
 
 
Table 1 
Number of cows with mastitis 
 
Types of mastitis Total number of cows  Number of sick cows Sickness indicator  (%) 
Subclinical Mastitis 
120 
64 53,3% 
Catarral  8 6,6% 
Purulent-catarrhal  7 5,8% 
 
In order to determine the therapeutic efficacy of the 
drug, 64 cows, sick with subclinical mastitis, 8-catarrhal, 
7-purulent-catarrhal mastitis were selected from three 
farms during the year. 
For treatment, two schemes were used. For cows with 
catarrhal and purulent-catarrhal mastitis in the first 
scheme, Mastiet forte, ketoprof and vitamin  of Khelsivit 
were used. And cows with subclinical mastitis were treat-
ed with mastitis forte and clinex 5%, with vitamin of  
Helsivit. 
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Table 2 
A scheme of treatment of mastitis No. 1 
 
Name of the drug Use Dose Days of treatment 1 2 3 4 5 
Mastiet Forte intracisternally 1 syringe dispenser ++ ++ ++ ++ ++ 
Ketoprof intramuscularly 3 ml per 100 kg + + +   
Vitamin of  Helsivit  intramuscularly 6 ml +     
 
Table 3  
A scheme of treatment of mastitis No. 2 
  
Name of the drug Use Dose Days of treatment 1 2 3 4 5 
Mastiet Forte intracisternally 1 syringe dispenser ++ ++ ++ ++ ++ 
Klineksin 5% intramuscularly 1 ml per 50 kg + + +   
Vitamin of  Helsivit intramuscularly 6 ml +     
 
Mastiet forte was used intracisternally for five days at 
a dose of 10 ml 2 times a day for five days in a row. 
Mastiet Forte has a high therapeutic efficacy in subclini-
cal and clinical forms of cow mastitis. After the drug was 
injected, a light massage of the affected quarter of the 
udder was performed to evenly distribute the drug in the 
lobe. And the drug ketoprof was also used. Ketoprof as an 
anti-inflammatory agent was used intramuscularly – 3 ml 
per 100 kg of animal weight 1 time per day for 3 days in a 
row. Klineksin 5%, as an antibacterial agent, was used 
intramuscularly at a dose of 1 ml per 50 kg of body 
weight 1 time per day for 3 days in a row. Antimicrobial 
agents and biologically active substances needed to be 
combined for successful therapy. Such biologically active 
substances include vitamin of Helsivit. Helsivit was used 
subcutaneously – 6 ml once. 
Laboratory studies conducted in the apparatus “Lak-
tan1-4M” for the presence of somatic cells in milk 3 days 
after the first treatment scheme  were within 480 thou-
sand, and in the second treatment scheme  were 490 thou-
sand somatic cells. 
After five days after the last use of drugs, the results 
of the treatment were evaluated. The recovery of cows 
with subclinical and clinical forms of mastitis was again 
determined and the milk of all quarters of the udder was 
examined after 3–5 days by DEDM (Device for Express 
Diagnostic of Mastitis) and the California test. The cows 
were considered recovered if the milk sample showed a 
low content of somatic cells (up to 200,000 v1 cm3 of 
milk), there were no changes in the secret. 
The effectiveness of the treatment of the first scheme 
was 93%, and in the second scheme was 95%. 
Thus, our research and complex treatment gave a very 
good result, not only in the treatment of these cows, but 
also prophylactic efficacy in the conducted research of the 
farms. 
Therefore, the study of specific causes contributing to 
the occurrence of these diseases, their diagnosis, treat-
ment and prevention are of great practical importance. 
 
 
 
 
Conclusions 
 
Drugs of the first and second schemes have a high 
therapeutic activity, which has reduced the time of treat-
ment of subclinical and clinical mastitis, as well as the 
timing of culling milk. In both cases of the use of mastiet 
forte, there was not noted its negative effect on the gen-
eral condition of the animals, local irritant or sensitizing 
effect of the drug. With the introduction of the drug in 
dairy tanks, the active ingredients penetrate the udder 
parenchyma, remaining in therapeutic concentrations for 
12 hours. 
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